SMi are proud to present the 2013 Advances and Progress in Drug Design conference, convening in Central London on Monday 18th and Tuesday 19th February 2013

This exciting event will focus on the latest developments in the fast-paced field and will be a perfect opportunity to hear presentations on CADD Optimization Strategies, Kinetics-Based Drug Design, FBDD and Water Binding Site Analysis and network with key industry professionals.

KEY BENEFITS OF ATTENDING

• Consider computational approaches to polypharmacology and mode-of-action analysis
• Understand applications of CADD to protein therapeutics
• Evaluate drug design strategies for anti-virals and combating resistance
• Discover the latest development in water network perturbation in structure-based drug design
• Discuss the discovery of novel inhibitors through structure-based fragment evolution
• Hear from the industry on the influence of kinetic and thermodynamic signatures on hit-and-lead optimization
• Capitalize on the latest in data integration and developments in public-private partnerships
• Network and learn from key opinion leaders from industry and academia on protein-protein interactions

OUR EXPERT SPEAKER LINE UP INCLUDES

• Nicolas Baurin, Drug Design Lead Generation Group Head, Sanofi-Aventis
• Jose Duca, Head, Computer-Aided Drug Discovery, Novartis
• Albert Pan, Research Scientist, D. E. Shaw Research
• Andrew Leach, Director of Biomolecular Structure, GlaxoSmithKline
• Harald Mauser, Senior Scientist, Roche
• Ola Fjellström, Associate Principal Scientist, AstraZeneca
• Herman van Vlijmen, Senior Director, Johnson and Johnson
• John Mathias, Head of Medicinal Chemistry - Inflammation & Remodelling, Pfizer
• Matthias Frech, Head of Molecular Interaction & Biophysics, Merck KGAA
• Steven Charlton, Director, Receptor Biology, Novartis

Also don’t miss the chance to attend two of our interactive workshops:

Fragment-Based Lead Discovery: Issues and Applications
In Association with: Vernalis
Wednesday 20th February 2013 9.00am – 12.30pm

Binding Kinetics for Drug Design: the Molecular and Structural Perspective
In Association with: ICREA
Wednesday 20th February 2013 1.30pm – 5.00pm

For more information click here